ARK Investment Management’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,800,797
Closed -$49.1M 347
2022
Q2
$49.1M Sell
5,800,797
-202,026
-3% -$1.74M 0.29% 54
2022
Q1
$66.5M Buy
6,002,823
+1,257,154
+26% +$14.1M 0.28% 56
2021
Q4
$83.4M Buy
4,745,669
+1,157,129
+32% +$22.4M 0.25% 62
2021
Q3
$72.7M Buy
3,588,540
+333,437
+10% +$8.57M 0.17% 86
2021
Q2
$108M Buy
3,255,103
+2,156,834
+196% +$81.4M 0.2% 85
2021
Q1
$42.9M Buy
+1,098,269
New +$51.6M 0.09% 139

Other funds holding ONEM

ARK Investment Management's ONEM Position: Q3 2022 in Review

ARK Investment Management sold out of 1Life Healthcare (ONEM) in Q3 2022, closing a stake of 5,800,797 shares — an estimated $49.1M sold.

ARK Investment Management first reported a position in ONEM in Q1 2021 and held it in 6 quarters. The position peaked at $108M in Q2 2021. 222 funds tracked by Wall St. Rank hold ONEM as of Q3 2022.

  • ARK Investment Management reported no remaining 1Life Healthcare position as of Q3 2022 after selling out during the quarter.
  • ARK Investment Management sold 5,800,797 1Life Healthcare shares in Q3 2022, an estimated $49.1M.
  • ARK Investment Management first reported a position in 1Life Healthcare in Q1 2021 and held it in 6 quarters.
  • ARK Investment Management's 1Life Healthcare position peaked at $108M in Q2 2021.
  • 222 funds tracked by Wall St. Rank held 1Life Healthcare as of Q3 2022.

Based on ARK Investment Management's 13F filing for Q3 2022, filed 17 Oct 2022.